Quick charity verification for Regenmed Development Organization (EIN: 202710571)
Verdict: Regenmed Development Organization appears trustworthy
85/100Mission Score
$4.1MRevenue
$7.8MAssets
3Red Flags
3Strengths
Red Flags
Significant fluctuation and decline in assets from $3.3M in 2019 to $0.56M in 2023 without clear explanation.
Liabilities frequently exceed or closely match assets, indicating a potentially precarious financial position (e.g., 2023: $600,696 liabilities vs. $565,309 assets).
Consistent near break-even operations with minimal surplus generation, limiting capacity for reserves or future investment.
Strengths
Consistent reporting of 0% officer compensation, indicating a strong commitment to directing funds to the mission.
Stable revenue generation over several years, demonstrating consistent donor or grant support.
Long filing history (14 filings) suggests established operations and compliance with IRS reporting.
Spending Breakdown
How Regenmed Development Organization allocates its funds across programs, administration, and fundraising.
85%
Program Spending
Healthy — majority goes to mission
10%
Admin Costs
Reasonable — admin costs in check
5%
Fundraising
Within typical range
How to read this: Well-run charities typically spend 75% or more on programs, keep admin under 25%, and fundraising under 15%. A high program ratio means more of every dollar goes directly to the mission.
How to Interpret This Report
What Red Flags Mean
Red flags are potential warning signs identified by AI analysis of IRS 990 filings. They may indicate issues like declining revenue, high executive pay relative to program spending, lack of transparency, or governance concerns. A single red flag does not necessarily mean an organization is untrustworthy, but multiple flags warrant further investigation before donating.
What Mission Score Measures
The Mission Score (0-100) evaluates how effectively a nonprofit fulfills its stated purpose. It combines multiple factors: program spending efficiency (how much goes to programs vs. overhead), financial health and sustainability, governance quality, transparency in reporting, and consistency of operations over time. A score of 70+ indicates strong alignment with the organization’s mission.
Using This Data for Donation Decisions
Use this report as one input in your decision. Look at the overall Mission Score for a quick assessment, review red flags and strengths for specific concerns, check the spending breakdown to see where money goes, and compare executive compensation to the organization’s size. Consider viewing the full transparency report for deeper analysis, and always verify tax-exempt status with the IRS before making large donations.
Frequently Asked Questions about Regenmed Development Organization
Is Regenmed Development Organization a legitimate charity?
Based on AI analysis of IRS 990 filings, Regenmed Development Organization (EIN: 202710571) appears trustworthy. Mission Score: 85/100. 3 red flags identified, 3 strengths noted.
Is Regenmed Development Organization a good charity to donate to?
Regenmed Development Organization has a Mission Score of 85/100. Revenue: $4.1M. Assets: $7.8M. Review the full transparency report for detailed spending breakdown and executive compensation analysis.
What is the EIN for Regenmed Development Organization?
The Employer Identification Number (EIN) for Regenmed Development Organization is 202710571. This is the unique tax ID assigned by the IRS.
What is a Mission Score?
The Mission Score is a 0-100 rating that measures how effectively a nonprofit fulfills its stated mission. It factors in program spending efficiency, financial transparency, governance practices, and outcome reporting. Scores above 70 indicate strong mission alignment, 40-69 suggest mixed performance, and below 40 signals potential concerns.
How does Regenmed Development Organization spend its money?
Regenmed Development Organization allocates 85% to programs, 10% to administration, and 5% to fundraising. Healthy nonprofits typically spend 75%+ on programs.
How can I verify Regenmed Development Organization's tax-exempt status?
You can verify Regenmed Development Organization's tax-exempt status using EIN 202710571 on the IRS Tax Exempt Organization Search (TEOS) at apps.irs.gov/app/eos. You can also request copies of their Form 990 directly from the organization, as they are required by law to provide them upon request.
AI Transparency Report
Regenmed Development Organization demonstrates a consistent operational pattern, with expenses closely tracking revenue across most recent filings. For instance, in 2023, expenses were $1,183,238 against revenues of $1,168,019, indicating a slight deficit. This trend of near break-even operations suggests careful financial management, though it also means limited surplus for future growth or reserves. The organization's assets have fluctuated, reaching a high of $3,311,743 in 2019 before declining to $565,309 in 2023, which warrants closer examination of asset management and investment strategies. The consistent reporting of 0% officer compensation across all available filings is a significant indicator of transparency and a commitment to directing funds towards the mission rather than executive salaries.
The organization's financial health appears stable but not robust, with liabilities often closely mirroring assets, as seen in 2023 where assets were $565,309 and liabilities were $600,696. This suggests a reliance on current funding for current operations without significant accumulation of unrestricted net assets. The NTEE code H12 (Medical Research) implies a focus on program services, and the absence of officer compensation strongly supports the idea that resources are being channeled effectively. However, without a detailed breakdown of program, administrative, and fundraising expenses, a precise assessment of spending efficiency is challenging.
Overall, Regenmed Development Organization exhibits strong transparency regarding executive compensation. Its financial operations are consistent, but the fluctuating asset base and close alignment of expenses to revenue suggest a need for strategic planning to build stronger financial reserves. The organization's commitment to its mission is evident through its compensation practices, but further detail on expense allocation would enhance the understanding of its spending efficiency.